For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260128:nRSb6194Qa&default-theme=true
RNS Number : 6194Q Pets At Home Group Plc 28 January 2026
FOR IMMEDIATE RELEASE, 28 JANUARY 2026
Pets at Home Group Plc: Q3 FY26 Trading Statement
for the 12 week period to 1 January 2026
Performance in line; FY26 uPBT to be in line with consensus
Highlights
· Group consumer revenue(1) up by 0.8% to £472m.
· Vet Group consumer revenue up 5.0%, performance was in line with
our expectations, with growth supported by average transaction values and
growth in Care Plan revenues and plans.
· Retail consumer revenue down 1.1% included positive volume growth
across food and accessories. Q3 saw sequential improvement in growth during a
period where we invested in our relative price position. Online remains the
fastest growing channel, delivering low teens growth throughout the quarter.
· Total Group statutory revenue down 1.0% to £358m, with Group
like-for-like(2) (LFL) revenue down 0.7%.
· Q3 retail transactions were broadly flat. This is currently a
better underlying indicator of our customer health than Pet Club members which
dropped 6.9% to 7.6m in part due to a change in methodology(9), which has also
had a corresponding positive impact on Average Consumer Value.
· Retail consumer satisfaction remains high, increasing +3pts vs Q3
last year led by improvements in value for money, colleague service and
availability.
· Subscription sales remained in strong growth, now representing
15.0% of our consumer revenues. 5% of Pets Club members now have an Easy
Repeat subscription, with more than 50% of Vet clients having a Care Plan.
· Vet expansion plans on track, with 10 new practices and 15 vet
extensions to be delivered in FY26.
Current trading and outlook
· Q3 fell within the range of our expectations and we expect to
deliver FY26 underlying PBT in line with current consensus*
· All other guidance remains unchanged from our interims
announcement.
Ian Burke, Interim Executive Chair:
"Our dedicated pet care colleagues and veterinary partners helped us to
deliver a solid Q3 performance, which will enable us to achieve an FY26
underlying PBT outcome in line with consensus expectations.
"I'm pleased to report continued strong performance in our Vet business and
sequential improvement in Retail, as we continue to implement our Retail
Turnaround Plan. One of our key early actions as part of this plan included
investing in our customer offer, reducing the price of over 1,000 products by
an average of 12%, ensuring our customers know they can trust us to provide
great value for them and their pets.
"With a new CEO and CFO joining in spring, our focus for the remainder of the
year is on building momentum behind our four turnaround plan priorities of
Price, Product, Cost and Execution, to deliver our FY26 plan and to return our
Retail business to sustainable sales and profit growth."
*current consensus £93m with a range of £90-97m
Key Performance Indicators
Strategic KPIs FY26 YTD FY25 YTD YoY
Number of active Pets Club members(3) (m) 7.6(9) 8.2 (6.9)%
Average Consumer Value(4) (£) 193(9) 177(7) 9.4%
% of Consumer Revenue from Subscriptions(5) (%) 15.0% 12.1%(8) 24.1%
Clinical FTE Headcount(6) (k) 3.6 3.5 3.3%
1. Consumer revenue includes total revenue across the Group
including consumer sales made by Joint Venture vet practices, and therefore
differs to the fee income recognised within Vet Group statutory revenue.
2. Like-for-like revenue comprises total revenue in a
financial period compared to revenue achieved in a prior period, for stores,
omnichannel operations, grooming salons, and vet practices that have been
trading more than 52 weeks prior to both the current and prior period
reporting date.
3. Number of active Pets Club members who transacted across
the group in the last 365 days prior to the end of the reporting period.
4. The average spend of active Pets Club members across the
group over the last 365 days based on consumer revenue as defined above,
rather than statutory revenue.
5. Subscription revenue includes our Flea & Worm, Easy
Repeat, Complete Care and Vac4Life plans and is divided by Group consumer
revenue.
6. Full time equivalent number of all vets and nurses working
across the group, based on standard working hours.
7. Restated from £175, based on previous Pet Club member
methodology.
8. Restated from 12.7%, prior year now reporting against the
last 365 days prior to the end of the reporting period.
9. In April 2025 we implemented a change in how store
colleagues are able to look up Pet Club member records in our till system.
This resulted in a reduction in lower spending customers in our active Pets
Club members base. Correspondingly, the number of non-Pets Club transactions
have increased. It is not possible to restate prior quarters numbers to
reflect this change.
Our next scheduled update will be a pre-close update towards the end of March.
Investor Relations Enquiries
Pets at Home Group Plc:
Andrew Porteous, Director of Investor Relations +44 (0) 7740 361 849
Aaron Wood, Head of Investor Relations +44 (0) 7702 083 154
Media Enquiries
Pets at Home Group Plc:
Natalie Cullington, Head of Communications +44 (0) 7974 594 701
Citigate Dewe Rogerson:
Angharad Couch +44 (0) 7507 643 004
About Pets at Home
Pets at Home Group Plc is the UK's leading pet care business, providing pets and their owners with the very best advice, products and care. Pet products are available online or from over 450 pet care centres, many of which also have vet practices and grooming salons. The Group also operates a leading small animal veterinary business, with over 450 veterinary general practices located both in our pet care centres and in standalone locations. For more information visit:
http://petsathomeplc.com/ (http://petsathomeplc.com/)
Disclaimer
This trading statement does not constitute an invitation to underwrite,
subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc
shares or other securities nor should it form the basis of or be relied on in
connection with any contract or commitment whatsoever. It does not constitute
a recommendation regarding any securities. Past performance, including the
price at which the Company's securities have been bought or sold in the past,
is no guide to future performance and persons needing advice should consult an
independent financial adviser. Certain statements in this trading statement
constitute forward-looking statements. Any statement in this document that is
not a statement of historical fact including, without limitation, those
regarding the Company's future plans and expectations, operations, financial
performance, financial condition and business is a forward-looking statement.
Such forward-looking statements are subject to risks and uncertainties that
may cause actual results to differ materially. These risks and uncertainties
include, among other factors, changing economic, financial, business or other
market conditions. These and other factors could adversely affect the outcome
and financial effects of the plans and events described in this statement. As
a result, you are cautioned not to place reliance on such forward-looking
statements. Nothing in this statement should be construed as a profit
forecast.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TSTUBSBRNAUAUAR
Copyright 2019 Regulatory News Service, all rights reserved